Skip to content

Clinical efficacy evaluation of optimizing tuina therapy for the treatment of lumbar disc herniation

Application and evaluation of Shao's philosophy in standardized tuina therapy for lumbar disc herniation

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087388
Enrollment
Unknown
Registered
2024-07-26
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar disc herniation

Interventions

Optimization Tuina Group:Referring to the "Shao Mingxi Clinical Tuina Experience Collection" and the "Pelvic Traction Technique" (Zhang Shinian, a multicenter randomized controlled study on staged tre
Conventional Tuina Group:Referring to the LDH treatment plan in "Tuina Therapy" (Song Bolin, Yu Tianyuan. Tuina Therapy. Beijing: People's Health Publishing House, 2012), treatment is performed 6 time

Sponsors

Affiliated Hospital of Nanjing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Simultaneously meeting the diagnostic criteria of LDH in both traditional Chinese and Western medicine; Age >=18 years and <= 70 years, disease duration <= 3 years; Mainly characterized by discomfort in one side of the waist and legs, without surgical treatment; Informed consent, voluntary testing. The process of obtaining informed consent should comply with GCP regulations.

Exclusion criteria

Exclusion criteria: Patients with severe primary diseases including heart, brain, liver, kidney, and hematopoietic system; Patients who abuse psychotropic drugs and those with mental disorders; Patients with lumbar spinal stenosis caused by other reasons; Individuals with single nerve paralysis or cauda equina paralysis, manifested as muscle paralysis or rectal or bladder symptoms; According to the researcher's judgment, other lesions that may reduce the likelihood of inclusion or complicate inclusion, such as frequent changes in the work environment, are prone to loss to follow-up; Patients currently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Visual Analogue Scale;Japanese Orthopaedic Association Scores;EMG detection;

Countries

China

Contacts

Public ContactSang Jiajia

Affiliated Hospital of Nanjing University of Chinese Medicine

sangtcm@163.com+86 150 0515 6701

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026